BIT Biotech Opportunities I-II Fonds
115,89
EUR
-1,87
EUR
-1,59
%
NAV
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Viridian Therapeutics Inc | US92790C1045 | 9,69% |
| IDEAYA Biosciences Inc | US45166A1025 | 6,13% |
| Beam Therapeutics Inc | US07373V1052 | 6,06% |
| Revolution Medicines Inc Ordinary Shares | US76155X1000 | 5,24% |
| ATAI Life Sciences NV | NL0015000DX5 | 5,09% |
| Cytokinetics Inc | US23282W6057 | 5,05% |
| Immunome Inc Ordinary Shares | US45257U1088 | 5,02% |
| Enliven Therapeutics Inc | US29337E1029 | 4,82% |
| Agios Pharmaceuticals Inc | US00847X1046 | 4,61% |
| Immunocore Holdings PLC ADR | US45258D1054 | 4,54% |
| Sonstige | 43,74% |